Clinical Implementation of 177Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges

被引：8
|
作者：
Ravi, Praful [1 ]
Whelpley, Bridget [1 ]
Kelly, Emma [1 ]
Wolanski, Andrew [1 ,2 ]
Ritzer, Jolivette [1 ,2 ]
Robertson, Matthew [1 ,2 ]
Shah, Hina [1 ,2 ]
Morgans, Alicia K. [1 ]
Wei, Xiao X. [1 ]
Sunkara, Rajitha [1 ]
Pomerantz, Mark [1 ]
Taplin, Mary -Ellen [1 ]
Kilbridge, Kerry L. [1 ]
Choudhury, Atish D. [1 ]
Jacene, Heather [1 ,2 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷 / 03期
关键词：
RESISTANT PROSTATE-CANCER; MULTICENTER; THERAPY;
D O I：
10.2967/jnumed.122.265194
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：349 / 350
页数：2
相关论文
共 45 条
  • [21] 225Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177Lu-PSMA-617 Radioligand TherapyPilot Experience From a Prospective Registry
    Rosar, Florian
    Burgard, Caroline
    Rohloff, Luna Vanessa
    Blickle, Arne
    Bartholomae, Mark
    Maus, Stephan
    Petto, Sven
    Schaefer-Schuler, Andrea
    Ezziddin, Samer
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : 621 - 629
  • [22] Real-World Experience with 177Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval
    Tuchayi, Abuzar Moradi
    Yadav, Surekha
    Jiang, Fei
    Kim, Sarasa T.
    Saelee, Rachelle K.
    Morley, Amanda
    Juarez, Roxanna
    Lawhn-Heath, Courtney
    Wang, Yingbing
    de Kouchkovsky, Ivan
    Hope, Thomas A.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (05) : 735 - 739
  • [23] Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving 177Lu-PSMA-617
    Kessel, Katharina
    Seifert, Robert
    Schaefers, Michael
    Weckesser, Matthias
    Schlack, Katrin
    Boegemann, Martin
    Rahbar, Kambiz
    THERANOSTICS, 2019, 9 (17): : 4841 - 4848
  • [24] Therapeutic Multidose Preparation of a Ready-to-Use 177Lu-PSMA-617 Using Carrier Added Lutetium-177 in a Hospital Radiopharmacy and Its Clinical Efficacy
    Chakraborty, Avik
    Mitra, Arpit
    Tawate, Megha
    Sahoo, Sudip
    Lad, Sangita
    Rakshit, Sutapa
    Gaikwad, Sujay
    Basu, Sandip
    Shimpi, Hemant
    Banerjee, Sharmila
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2021, 36 (08) : 682 - 692
  • [25] Preparation of 177Lu-PSMA-617 in Hospital Radiopharmacy: Convenient Formulation of a Clinical Dose Using a Single-Vial Freeze-Dried PSMA-617 Kit Developed In-House
    Guleria, Mohini
    Amirdhanayagam, Jeyachitra
    Sarma, Haladhar D.
    Rallapeta, Ramya Priya
    Krishnamohan, V. S.
    Nimmagadda, Ajit
    Ravi, Parthasarathy
    Patri, Sailaja
    Kalawat, Tekchand
    Das, Tapas
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [26] 225Ac-PSMA-617 Augmentation After Insufficient Response Under 177Lu-PSMA-617 Radioligand Therapy in mCRPC: Evaluation of Outcome and Safety From a Prospective Registry (REALITY Study)
    Rosar, Florian
    Khreish, Fadi
    Nagel, Lea Sophie
    Blickle, Arne
    Burgard, Caroline
    Petto, Sven
    Bastian, Moritz B.
    Speicher, Tilman
    Bartholomae, Mark
    Maus, Stephan
    Schaefer-Schuler, Andrea
    Ezziddin, Samer
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (04) : e202 - e206
  • [27] Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies
    Kuo, Hsiou-Ting
    Merkens, Helen
    Zhang, Zhengxing
    Uribe, Carlos F.
    Lau, Joseph
    Zhang, Chengcheng
    Colpo, Nadine
    Lin, Kuo-Shyan
    Benard, Francois
    MOLECULAR PHARMACEUTICS, 2018, 15 (11) : 5183 - 5191
  • [28] Automated radiosynthesis of [68Ga]Ga-PSMA-11 and [177Lu]Lu-PSMA-617 on the iPHASE MultiSyn module for clinical applications
    Wichmann, Christian W.
    Ackermann, Uwe
    Poniger, Stan
    Young, Kenneth
    Nguyen, Benjamin
    Chan, Gordon
    Sachinidis, John
    Scott, Andrew M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2021, 64 (03) : 140 - 146
  • [29] 68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
    de Vries, Lisa H.
    Lodewijk, Lutske
    Braat, Arthur J. A. T.
    Krijger, Gerard C.
    Valk, Gerlof D.
    Lam, Marnix G. E. H.
    Rinkes, Inne H. M.
    Vriens, Menno R.
    de Keizer, Bart
    EJNMMI RESEARCH, 2020, 10 (01)
  • [30] Influence of short-term dexamethasone on the efficacy of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Derlin, Thorsten
    Sohns, Jan M. Sommerlath
    Schmuck, Sebastian
    Henkenberens, Christoph
    von Klot, Christoph A. J.
    Ross, Tobias L.
    Bengel, Frank M.
    PROSTATE, 2020, 80 (08) : 619 - 631
12345